Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000899243-21-026340

Options or other derivatives

  • Director acquired 13,755,415 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jerel Davis Director 2021-02-16 Grant or award · Series A Preferred Stock +10,000,000 $1.00 $10,000,000 30,019,945 I
Jerel Davis Director 2021-03-11 Grant or award · Series B Preferred Stock +3,715,415 $5.06 $18,800,000 3,715,415 I
Jerel Davis Director 2021-06-24 Grant or award · Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…